Robert G. Savage Added to Bexion’s Board of Directors
FOR IMMEDIATE RELEASE Covington, KY ~ 23 May 2019 Bexion Pharmaceuticals, Inc. (Bexion) announced today that the company has added Bob Savage, MBA to its Board of Directors. Robert G. Savage Mr. Savage brings to the Bexion Board over 40 years of experience in marketing, sales, drug development, operation and business development in the pharmaceuticals and biotechnological industries.